PT - JOURNAL ARTICLE AU - Sawant, Onkar B. AU - Singh, Sneha AU - Wright, Robert Emery AU - Jones, Kayla M. AU - Titus, Michael S. AU - Dennis, Eugene AU - Hicks, Eric AU - Majmudar, Parag A. AU - Kumar, Ashok AU - Mian, Shahzad I. TI - Prevalence of SARS-CoV-2 in human post-mortem ocular tissues AID - 10.1101/2020.10.05.20201574 DP - 2020 Jan 01 TA - medRxiv PG - 2020.10.05.20201574 4099 - http://medrxiv.org/content/early/2020/10/06/2020.10.05.20201574.short 4100 - http://medrxiv.org/content/early/2020/10/06/2020.10.05.20201574.full AB - Background SARS-CoV-2 is found in conjunctival swabs and tears of COVID-19 patients. However, the presence of SARS-CoV-2 has not been detected in the human eye to date. We undertook this study to analyze the prevalence of SARS-CoV-2 in human post-mortem ocular tissues.Methods The expression of SARS-CoV-2 RNA was assessed by RT-PCR in corneal and scleral tissues from 33 surgical-intended donors who were eliminated from a surgical use per Eye Bank Association of America (EBAA) donor screening guidelines or medical director review or positive COVID-19 test. Ocular levels of SARS-CoV-2 RNA (RT-PCR), Envelope and Spike proteins (immunohistochemistry) and anti-SARS-CoV-2 IgG and IgM antibodies (ELISA) in blood were evaluated in 10 COVID-19 donors.Findings Of 132 ocular tissues from 33 surgical-intended donors, the positivity rate for SARS-CoV-2 RNA was ∼13% (17/132). Of 10 COVID-19 donors, six had PCR positive post-mortem nasopharyngeal swabs whereas eight exhibited positive post-mortem anti-SARS-CoV-2 IgG levels. Among 20 eyes recovered from 10 COVID-19 donors: three conjunctival, one anterior corneal, five posterior corneal, and three vitreous swabs tested positive for SARS-CoV-2 RNA. SARS-CoV-2 spike and envelope proteins were detected in epithelial layer of the corneas that were procured without Povidone-Iodine (PVP-I) disinfection.Interpretations Our study showed a small but noteworthy prevalence of SARS-CoV-2 in ocular tissues from COVID-19 donors. These findings underscore the criticality of donor screening guidelines, post-mortem nasopharyngeal PCR testing and PVP-I disinfection protocol to eliminate any tissue harboring SARS-CoV-2 being used for corneal transplantation.Funding Research grant from EBAA and National Institutes of Health.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by research grants from the Eye Bank Association of America and National Eye Institute (AK EY027381 EY026964) and National Institute of Allergy and Infectious Diseases (AK AI135583 AI140033).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was performed in compliance with the Declaration of Helsinki and Eye Bank Association of America (EBAA) and Food and Drug Administration (FDA) regulations. Consent for research was obtained prior to procurement from each donor family. The University of Michigan medical school institutional review board (IRBMED) determined that this study does not fit the definition of human subjects research requiring IRB approval. Laboratory experiments from this study were approved by the Institutional Biosafety Committee (IBC) at the Wayne State University (IBC# 20-04-2164).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe (investigators) have access to all the data represented in this manuscript.